A COMPARATIVE STUDY OF INTRAOCULAR PRESSURE LOWERING EFFECT OF 2% DORZOLAMIDE AND 0.5% TIMOLOL IN POAG
Journal Title: Journal of Evidence Based Medicine and Healthcare - Year 2017, Vol 4, Issue 42
Abstract
BACKGROUND Glaucoma is an optic neuropathy in which there is characteristic structural damage to the optic nerve head associated with widespread progressive ganglion cell death, nerve fibre loss and typical visual field defects. MATERIALS AND METHODS The patients were selected from the Outpatient Department of Ophthalmology, Nalanda Medical College, Patna. A total of 100 cases of primary open-angle glaucoma were selected from those attending the outpatient department. They were divided into various groups and comparative study was done. Group 1- IOP between 20-30 mmHg. Group2- IOP above 30 mmHg. Group 1 had total 60 patients whereas group 2 had total 40 patients. Each group were further divided into subgroups A and B. Subgroup A included those on timolol maleate (0.5%), whereas subgroup B those on dorzolamide hydrochloride (2%). Patients who had intraocular surgery and those on systemic beta blockers were excluded from this study. Patients were instructed not to administer their eye drops on the morning of the checkup visits in order to measure drug efficacy 12 hours after previous evening dose. RESULTS Group 1- There was a mean reduction of 6.2 ± 1.85 (22.94%) and 5.55 ± 1.68 (21.38%) mm of Hg in right and left eye respectively with timolol, whereas dorzolamide group showed a reduction of 3.91 ± 1.69 (14.04%) respectively in right and left eye. Group 2- There was a mean reduction of 4.72 ± 2.97 (15.73%) and 5.3s7 ± 1.24 (16.26%) in right and left eye respectively with timolol, whereas dorzolamide group showed a reduction of 4.30 ± 1.41 (12.90%) and 4.12 ± 2.08 mmHg (12.56%) in right and left eye, respectively. CONCLUSION Timolol maleate (0.5%) has an edge over dorzolamide hydrochloride (2%) as far as IOP lowering effect is concerned.
Authors and Affiliations
Navin Chandra, Suresh Kumar Sinha
Keywords
Related Articles
- EP ID EP219916
- DOI 10.18410/jebmh/2017/512
- Views 124
- Downloads 0
PREVALENCE OF CHOLESTATIC JAUNDICE IN CHILDREN – A STUDY IN HOSPITALISED CHILDREN
INTRODUCTION A study conducted in 58 cases of children who were admitted and evaluated over a period of 2 years October 2013 to November 2015 to find out the prevalence of cholestatic jaundice in children. This study con...
PULMONARY HYPERTENSION IN HYPOTHYROIDISM- A PROSPECTIVE, INTERVENTIONAL STUDY
BACKGROUND Hypothyroidism, a frequent endocrine disorder affects ~11% of the Indians. Though there are studies reporting the cooccurrence of hypothyroidism and Pulmonary Arterial Hypertension (PAH), evidence-based litera...
AWARENESS OF DIAGNOSIS AMONG CANCER PATIENTS AND ITS OUTCOME
BACKGROUND Clinical experience and research evidence suggests that in India many cancer patients are not informed about their diagnosis and prognosis. Previous studies have demonstrated an increased risk for psychiatric...
CLINICAL OUTCOME WITH ADD ON RACECADOTRIL VERSUS STANDARD CARE IN PAEDIATRIC GASTROENTERITIS – OUR EXPERIENCE
BACKGROUND Acute gastroenteritis (AGE) is a diarrheal disease of rapid onset, with an increase in the water content, volume, or frequency of stools and often self-limiting. The WHO recommends ORS as the treatment of choi...
EVALUATION OF LIPID PROFILE IN NON-DIABETIC CHRONIC KIDNEY DISEASE STAGE 3 AND 4
CVD are the major cause of mortality in patient with CKD. One of the established risk factor for cardiovascular disease is dyslipidemia. The pattern of dyslipidemia in CKD is entirely different from general population. S...